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Abstract 
This paper propose to develop statistical measures of case recovery rate assuming that patient recovery is 
influenced by two factors acting simultaneously, that is, to develop a two way analysis of case recovery rate for a 
disease. The specific rates which are useful in identifying segments of the population that are at elevated risk of a 
given disease and would need a more aggressive medical and health interventionist measures to alleviate the 
disease compared with the average number of the general population at risk were estimated. Case recovery rate 
has shown to possibly serve as a measure of morbidity of a disease in a population especially if the disease is not 
virulent.  It is shown that the smaller this rate is, the more likely is the disease morbid in the population and vice 
versa.  It is also shown under certain condition that case recovery rate when used as a measure of survivorship or 
morbidity from a disease must be used and interpreted with great caution because of definitional problems. The 
propose method was illustrated with some data.  
Keywords:  Case fatality, Recovery rate, Crude rate, Adjusted and Unadjusted rates, Treatment, Survivorship, 
Morbidity 
 
1.  Introduction 
The concept of case fatality rate, the number of deaths due to a certain disease per infected population at risk 
during a specific time period is often used as a gauge of the virulence of a disease and of the success of its 
treatment and management strategies. However, the concept of case recovery rate have been defined as the 
number of persons who recovered from a certain disease per population at risk marked by the cessation of the 
relevant  symptoms during a specified period of time. (Zar 1984, 1996;  Fleiss, 1981, Cohen 1988). It may also 
be used as a measure of the success of the disease treatment and management program. (Crawford et al 1992, 
Yeates and Taylor 1997).  This may be a more relevant measure especially for life threatening highly virulent 
severe and acute disease outbreak including AIDS/HIV and  Ebola.  
(Daniel 1983;   Cole and MacMahon 1971; Cook,, Doll. and  Fellingham 1969; Hennekens and Buring 
1987, Cicchetti et al  1991, 1993 , Rourke, et al 1992 ). The prognosis of a disease is usually dependent on 
several factors including the demographic and socio-economic characteristics of the patient as well as the length 
of time that elapsed between disease onset and hospitalization   and available medical and health management 
technologies. These variables are usually associated with the occurrence of the event of interest as well as with 
one another.  (Kelly and Cowling 2013; Taubenberger Jeffrey and David 2006; Li et al 2008; King 2008, 
Cornfield 1951, Crawford, and Allan 1997 ). 
In this paper, we propose to develop statistical measures of case recovery rate assuming that patient 
recovery is influenced by two factors acting simultaneously, that is, we propose to develop a two way analysis of 
case recovery rate for a disease.  
1. 1:  Propose Method  
Let A with ‘a’ levels or strata and B with ‘b’ levels or strata be any two factors influencing the outcome of a 
certain disease during a specified time period. Let  be the number of persons at the  level of factor A and 
 level of factor B in the population at risk who contacted the disease within a specified time period, 
for  be  the corresponding number of persons who recovered 
from the disease within the specified period of time.. These two numbers may be written as the pair . 
The factor A by factor B case specific recovery rate , at the level of factor A and  level of factor B is 
then given  
   .                                      …………………1 
Let    be the number of persons in the population at risk infected by the disease at the  level 
of factor A for all levels of factor B and Let   the number of persons in the population at risk 
infected at the  level of factor B for all levels of factor A. The total number of persons in the infected 
population at risk of recovery or the infected population is   
Let   be the proportion of the population at risk infected at the ith level of factor A and    be 
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the proportion of the infected population at risk infected in the   level of  factor B.  Also let  be 
the proportion of the population at risk infected in the  level of factor A and the  level of factor B where  
 
 Let                                                         …………….2 
 be respectively the number of persons who recovered from the disease at the  level of factor A during the 
specified time period and  the  level of factor B who recovered from disease during the specified time period. 
Let                                      …………….3 
 be the total number of persons in the population at risk who recovered from the disease during the specified time 
period.  
Then the unadjusted factor A specific recovery rate at the  level of factor A, namely  is calculated as 
                                                     …………………4 
Similarly, the unadjusted specific recovery rate at the  level of factor B is given as  
                                                    …………………5  
Also, the overall total or crude unadjusted recovery rate from the disease during the specified time period is 
  
The specific rates in equations 1-3 are useful in identifying segments of the population that are at elevated risk of 
a given disease and would therefore be in need of more aggressive medical and health interventionist measures 
to alleviate the disease compared with the average number of the general population at risk.  
Further interest here is also often to obtain rates adjusted for the two factors of classification. As noted 
above, factors A and B are usually closely associated with the outcome of the disease as well as with each other. 
There are therefore likely to have confounding effects on the estimated rates. The rates standardization or 
adjustment is aimed at removing some of these effects. If the distribution of the population by the levels of the 
factors of classification is available as in the present case, then the method of standardization that readily 
suggests itself is the direct method.  
To apply the direct method of standardization, we use the overall distribution of the population at risk 
over the categories of factor B namely  as the standard population for adjusting the 
specific rates for the levels of factor A. Similarly, we use the overall distribution of the population at risk over 
the levels of factor A namely , as the standard population to apply in adjusting its specific 
rates for the levels of factor B.  
Thus, the direct standardized or adjusted recovery rate for the  level of factor A namely  direct is 
calculated as  
  
Similarly, the direct adjusted rate for the  level of factor B namely direct is given as  
  
The direct adjusted crude rate, r adj. direct resulting from equations 7 and 8 may be equal but are not necessarily 
equal to the unadjusted crude rate r obtained from equation 6 . 
The format of the calculation is presented in the following table. 
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Table1. Schematic Table Illustrating the Calculation of Specific and Direct Adjusted Rates in a Two - Way 
Classification 
Factor A 1 2 3 … b Proportion 
of Popn  
Unadjusted  
rate  
Direct adjusted 
rate  Direct
1 
   
… 
  .  direct 
2 
   
… 
   direct 
3 
   
… 
   direct 
. .        
A 
   
… 
  . direct 
Proportion 
of Popn  
   
 
 
 
 
 
Unadjusted 
rate  
   
 
   direct 
Direct 
adjusted rate 
Direct 
direct direct direct …  direct   
 
Table 2 : Distribution of Meningitis Patient and Number who recovered within two weeks of Treatment by Age  
of patients  and type of Medication. The 1st entry is the number of people who recovered and the 2nd entry is the 
number of meningitis patients treated for 2 weeks 
Age  Natural herbs Standard Drug New Drug Total  
< 10 5; 72 10; 130 13; 150 28; 352 
10-19 5;76 4; 59 7; 85 16; 220 
20-29 6; 114 4; 70 9; 108 19; 292 
30-39 3; 53 4;49 5;56 12;158 
40-49 4; 67 8; 105 4;52 16;224 
50+ 4; 60 5;63 7;78 16’201 
Total  29; 442 35; 476 45;529 107;1447 
The age by type of treatment specific rate are obtained by applying equation 1 to table 2. The results are 
presented in Table 3. 
 
Table 3: Age by Type of Treatment Meningitis Recovery Rate per 1000 Patients 
Age  Natural herbs Standard Drug New Drug Total  
< 10 69.4 76.9 86/7 79.5 
10-19 65.8 67.8 82.4 72.7 
20-29 52.6 57.1 83.3 65.1 
30-39 56.6 81.6 89.2 76.9 
40-49 59.7 76.2 76.9 71.4 
50+ 66.7 5;63 89/7 79.6 
Unadj type of treatment specific (r.j) 65.6 73.5 85/1 73.9 (r) 
As expected, recovery is dependent on type of medication, increasing from 65. 6 for natural herbs to a 
high level of 35.1 per thousand patients treated with new drug.  However, age specific recovery rates do not 
seem to have a consistent pattern with age. This finding will seem to indicate the need to develop appropriate 
strategies to re-orientate patients who tend to prefer use of natural herbs. 
Using equation 5, we calculate the direct adjusted specific recovery rates by age groups using the 
distribution of patients across types of treatment as the standard population. The calculation is shown in Table 4 
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Table 4: Calculation of Direct Adjusted Specific Recovery Rates by Age using Distribution of Patients by Types 
of Treatment as Standard Population (in Thousands) 
Age  Natural 
Herbs 
Standard 
Drug 
New 
Drug  
Unadjusted 
Rate  
Direct 
Adjusted  
 
69.4 76.9 86.7 79.5  
 
21.2 25.3 31.7  78.2 
  65.8 67.8 82.4 72.7  
 
20.1 22.3 30.2  72.6 
 
52.6 57.1 83.3 65.1  
 
16.0 18.8 30.5  65.3 
 
56.6 81.6 89.2 76.9  
 
17.3 26.8 32.6  76.8 
 
59.7 76.2 76.9 71.4  
 
18.2 25.1 28.2  71.5 
 
66.7 79.4 89.7 79.6  
 
20.3 26.1 32.8  79.2 
Total  65.6 73.5 85.1 73.9  
 
20.0 24.2 31.2  75.3 
Proportion of Patients in Treatment 
Type 
0.305 0,329 0.366    
Note that adjusted of age specific recovery rate for type of treatment slightly reduces these rates but not 
significantly, indicating that the type of treatment the patient receives may not be importantly associated with 
age of patient.  
Finally, the direct adjusted specific recovery rate by type of treatment using the distribution of affected 
patients by age as standard population is calculated from equation 6 as the results are presented in Table 5. 
Table 5:  Calculation of Direct Adjusted Specific Recovery Rates by Treatment using the  
Distribution of Patients by Age as Standard Population (in thousands) 
Age  Natural Drug Standard Drug New Drug Total  Proportion of 
Patients in Age  
Group 
 (Standard 
Popn)  
        
 
69.4 16.9 76.9 18.7 86.7  79.5 19.3 0.243 
  65.8 10.0 67.9 10.3 82.4  72.7 11.1 0.152 
 
52.6 10.6 57.1 11.5 83.3  65.1 13.2 0.2 
 
56.6 6.2 81.6 8.9 89.2  76.9 8.4 0.109 
 
59.7 9.3 76. 2 11.8 76.9  71.4 11.1 0.155 
 
66.7 9.3 79.4 11.0 89.7  79.6 11.1 0.139 
Unadjusted 
Specific  
 
65.6  73..5  85.1     
Direct Adj 
Specific rate  
 
 62.3  72.2    74.2  
It is observed that when type of treatment specific recovery rates is adjusted for age of patients, their 
values are slightly reduced for each treatment type, although the observed patient still remains. 
 
1.2: Conclusion  
We have in this paper proposed the concept of case recovery rate defined as the number of infected persons who 
recovered from a specific disease per population of persons infected with the disease within a specified time 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.6, No.12, 2016 
 
43 
period as a public health indicator. Both the unadjusted and adjusted factor specific rates help the public health 
worker to determine those factors and combination of factors that would need special public health and medical 
attention. 
As noted earlier, case fatality rate and case recovery rate may be used to measure the success of a 
disease management program in controlling disease. However, unlike case fatality rate, case recovery rate can 
also serve as a measure of morbidity of a disease in a population especially if the disease is not virulent. The 
smaller this rate is, the more likely is the disease morbid in the population but if the recovery rate is high, the 
chances that the disease is morbid may be small. 
Never the less, unlike case fatality rate which has an element of finality, case recovery rate when used 
as a measure of survivorship or morbidity from a disease must be used and interpreted with great caution 
because of definitional problems. Recovery is often a continuous process that may be prolonged especially with 
increasing age and compounded by other associated conditions that may affect recovery. However, if recovery is 
identified with certain physical factors such as resumption of usual economic and social activities with the 
cessation of some well defined primary symptoms, then the resumption of these activities and the cessation of 
these symptoms may be regarded as necessary and fairly sufficient indication of recovery.  Under these 
conditions, case recovery rate may serve as a good public health indicator.  
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